Sam Hare/LinkedIn
May 29, 2025, 12:43
UICC Highlights AI and Biomarker Advances in Lung Cancer Detection and Treatment
Union for International Cancer Control (UICC) shared a post on LinkedIn:
“AI has a huge potential to revolutionise how we treat cancer.” – Sam Hare, CEO & Co-Founder The HLH Imaging Group.
Advancements in technology, like AI-assisted imaging and biomarker testing, are transforming the early detection of lung cancer. By identifying cancer at more treatable stages, these innovations improve survival rates and lead to more precise treatments.
AI’s ability to analyse vast data sets helps detect tumours early, while biomarker testing enables targeted therapies, reducing trial-and-error approaches. To maximise these benefits, it’s crucial to support research and integrate these technologies into healthcare systems globally.
With continued investment, AI can significantly improve cancer care, offering hope for better outcomes and saving lives.”
UICC emphasized the transformative role of AI-assisted imaging and biomarker testing in improving early lung cancer detection and treatment precision, advocating for continued global research and integration into healthcare systems.
More posts featuring Union for International Cancer Control.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 3, 2025, 08:27
Jul 3, 2025, 08:16
Jul 3, 2025, 08:06
Jul 3, 2025, 07:56
Jul 3, 2025, 07:36
Jul 3, 2025, 07:35